| 0 |
HYPERMUTATION |
136 |
0.9714 |
| 1 |
LYMPHOID TISSUE HYPOPLASIA |
143 |
0.9346 |
| 2 |
THYMUS HYPOPLASIA |
144 |
0.8276 |
| 3 |
DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT |
1374 |
0.6226 |
| 4 |
HUMAN BOCAVIRUS INFECTION |
117 |
0.6190 |
| 5 |
CYSTITIS VIRAL |
221 |
0.5770 |
| 6 |
ENGRAFTMENT SYNDROME |
341 |
0.5770 |
| 7 |
VIRAL HAEMORRHAGIC CYSTITIS |
406 |
0.5702 |
| 8 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
1373 |
0.4962 |
| 9 |
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE |
659 |
0.4664 |
| 10 |
DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY |
440 |
0.4646 |
| 11 |
OVARIAN FAILURE |
246 |
0.4598 |
| 12 |
IDIOPATHIC PNEUMONIA SYNDROME |
135 |
0.4530 |
| 13 |
ACUTE GRAFT VERSUS HOST DISEASE |
2074 |
0.4526 |
| 14 |
ENGRAFT FAILURE |
129 |
0.4495 |
| 15 |
B-CELL LYMPHOMA RECURRENT |
244 |
0.4494 |
| 16 |
MANTLE CELL LYMPHOMA RECURRENT |
194 |
0.4460 |
| 17 |
ENCEPHALITIS CYTOMEGALOVIRUS |
195 |
0.4452 |
| 18 |
VENOOCCLUSIVE DISEASE |
1084 |
0.4326 |
| 19 |
ACUTE GRAFT VERSUS HOST DISEASE IN LIVER |
288 |
0.4006 |
| 20 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
1768 |
0.3998 |
| 21 |
CONGENITAL APLASIA |
123 |
0.3955 |
| 22 |
VENOOCCLUSIVE LIVER DISEASE |
1939 |
0.3923 |
| 23 |
CHRONIC GRAFT VERSUS HOST DISEASE |
1407 |
0.3893 |
| 24 |
HUMAN HERPESVIRUS 6 INFECTION |
720 |
0.3805 |
| 25 |
GRAFT VERSUS HOST DISEASE IN SKIN |
834 |
0.3782 |
| 26 |
CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN |
343 |
0.3704 |
| 27 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
778 |
0.3653 |
| 28 |
CYSTITIS HAEMORRHAGIC |
1426 |
0.3534 |
| 29 |
ADENOVIRUS INFECTION |
970 |
0.3341 |
| 30 |
BK VIRUS INFECTION |
1090 |
0.3229 |
| 31 |
EPSTEIN-BARR VIRUS INFECTION REACTIVATION |
423 |
0.3212 |
| 32 |
FOLLICULAR LYMPHOMA |
281 |
0.3193 |
| 33 |
NEUROBLASTOMA |
121 |
0.3159 |
| 34 |
GLIOBLASTOMA MULTIFORME |
254 |
0.3017 |
| 35 |
SECONDARY IMMUNODEFICIENCY |
353 |
0.2905 |
| 36 |
FEBRILE NEUTROPENIA |
18970 |
0.2857 |
| 37 |
EPSTEIN-BARR VIRAEMIA |
316 |
0.2849 |
| 38 |
HUMAN POLYOMAVIRUS INFECTION |
150 |
0.2825 |
| 39 |
GRAFT VERSUS HOST DISEASE IN LIVER |
200 |
0.2793 |
| 40 |
NEUTROPENIC INFECTION |
264 |
0.2759 |
| 41 |
HEPATITIS B REACTIVATION |
873 |
0.2748 |
| 42 |
GRAFT VERSUS HOST DISEASE |
1968 |
0.2734 |
| 43 |
DISSEMINATED ASPERGILLOSIS |
129 |
0.2733 |
| 44 |
FEBRILE BONE MARROW APLASIA |
1143 |
0.2687 |
| 45 |
MENINGITIS TUBERCULOUS |
149 |
0.2665 |
| 46 |
CYTOMEGALOVIRUS CHORIORETINITIS |
520 |
0.2664 |
| 47 |
MALIGNANT TRANSFORMATION |
117 |
0.2606 |
| 48 |
B-CELL TYPE ACUTE LEUKAEMIA |
182 |
0.2480 |
| 49 |
DIFFUSE LARGE B-CELL LYMPHOMA |
1899 |
0.2462 |
| 50 |
GLIOMA |
157 |
0.2442 |
| 51 |
JC VIRUS INFECTION |
389 |
0.2431 |
| 52 |
HYPOGAMMAGLOBULINAEMIA |
1562 |
0.2375 |
| 53 |
CENTRAL NERVOUS SYSTEM LYMPHOMA |
325 |
0.2357 |
| 54 |
PNEUMONIA CYTOMEGALOVIRAL |
456 |
0.2346 |
| 55 |
PREMATURE MENOPAUSE |
215 |
0.2327 |
| 56 |
HAEMATOTOXICITY |
2213 |
0.2327 |
| 57 |
CYTOMEGALOVIRUS VIRAEMIA |
1022 |
0.2295 |
| 58 |
PSEUDOMONAL SEPSIS |
401 |
0.2288 |
| 59 |
PARAINFLUENZAE VIRUS INFECTION |
347 |
0.2278 |
| 60 |
APLASIA |
434 |
0.2214 |
| 61 |
PLASMA CELL MYELOMA REFRACTORY |
296 |
0.2212 |
| 62 |
NEUTROPENIC SEPSIS |
1573 |
0.2200 |
| 63 |
NEUTROPENIC COLITIS |
455 |
0.2198 |
| 64 |
ACUTE PROMYELOCYTIC LEUKAEMIA |
223 |
0.2169 |
| 65 |
PULMONARY VENO-OCCLUSIVE DISEASE |
149 |
0.2129 |
| 66 |
GLIOBLASTOMA |
361 |
0.2114 |
| 67 |
ENTEROCOCCAL BACTERAEMIA |
223 |
0.2104 |
| 68 |
ENCEPHALITIS VIRAL |
256 |
0.2102 |
| 69 |
MUCOSAL INFLAMMATION |
5488 |
0.2094 |
| 70 |
KLEBSIELLA BACTERAEMIA |
198 |
0.2084 |
| 71 |
TUMOUR PSEUDOPROGRESSION |
228 |
0.2082 |
| 72 |
SYSTEMIC MYCOSIS |
243 |
0.2080 |
| 73 |
PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED |
123 |
0.2074 |
| 74 |
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER |
365 |
0.2063 |
| 75 |
TRANSPLANT FAILURE |
505 |
0.2058 |
| 76 |
VIRAEMIA |
281 |
0.2027 |
| 77 |
CYTOKINE RELEASE SYNDROME |
4063 |
0.2023 |
| 78 |
MYELODYSPLASTIC SYNDROME |
2907 |
0.2008 |
| 79 |
ASPERGILLUS INFECTION |
1310 |
0.1994 |
| 80 |
KLEBSIELLA SEPSIS |
224 |
0.1988 |
| 81 |
ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT |
513 |
0.1986 |
| 82 |
FUSARIUM INFECTION |
139 |
0.1986 |
| 83 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
1004 |
0.1971 |
| 84 |
SECOND PRIMARY MALIGNANCY |
1623 |
0.1949 |
| 85 |
CEREBRAL TOXOPLASMOSIS |
180 |
0.1927 |
| 86 |
CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT |
134 |
0.1923 |
| 87 |
PNEUMOCYSTIS JIROVECI PNEUMONIA |
425 |
0.1906 |
| 88 |
INFECTION REACTIVATION |
218 |
0.1904 |
| 89 |
CEREBRAL ASPERGILLOSIS |
116 |
0.1886 |
| 90 |
ACUTE MYELOID LEUKAEMIA |
2921 |
0.1872 |
| 91 |
STEM CELL TRANSPLANT |
455 |
0.1819 |
| 92 |
ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION |
168 |
0.1816 |
| 93 |
PSEUDOMONAL BACTERAEMIA |
155 |
0.1815 |
| 94 |
CYTOPENIA |
2221 |
0.1812 |
| 95 |
MYCOBACTERIUM CHELONAE INFECTION |
133 |
0.1800 |
| 96 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
1066 |
0.1798 |
| 97 |
CYTOMEGALOVIRUS INFECTION |
2980 |
0.1791 |
| 98 |
EPSTEIN-BARR VIRUS INFECTION |
1114 |
0.1781 |
| 99 |
ACUTE MYELOID LEUKAEMIA RECURRENT |
379 |
0.1764 |
| 100 |
TOXOPLASMOSIS |
190 |
0.1759 |
| 101 |
LEUKAEMIA RECURRENT |
294 |
0.1738 |
| 102 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
1433 |
0.1736 |
| 103 |
TUMOUR LYSIS SYNDROME |
1499 |
0.1702 |
| 104 |
CARDIOTOXICITY |
1518 |
0.1700 |
| 105 |
PERIPHERAL MOTOR NEUROPATHY |
238 |
0.1698 |
| 106 |
BRONCHOPULMONARY ASPERGILLOSIS |
1301 |
0.1676 |
| 107 |
SYSTEMIC CANDIDA |
411 |
0.1635 |
| 108 |
DIFFUSE ALVEOLAR DAMAGE |
188 |
0.1635 |
| 109 |
PNEUMOCYSTIS JIROVECII INFECTION |
195 |
0.1632 |
| 110 |
STREPTOCOCCAL BACTERAEMIA |
177 |
0.1627 |
| 111 |
BACTERIAL SEPSIS |
525 |
0.1610 |
| 112 |
POLYOMAVIRUS VIRAEMIA |
169 |
0.1591 |
| 113 |
OBLITERATIVE BRONCHIOLITIS |
207 |
0.1577 |
| 114 |
BONE MARROW TOXICITY |
185 |
0.1561 |
| 115 |
HEPATITIS B |
930 |
0.1542 |
| 116 |
PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL |
129 |
0.1530 |
| 117 |
VARICELLA ZOSTER VIRUS INFECTION |
317 |
0.1528 |
| 118 |
NEOPLASM RECURRENCE |
518 |
0.1526 |
| 119 |
ESCHERICHIA BACTERAEMIA |
359 |
0.1526 |
| 120 |
ENTEROCOCCAL SEPSIS |
123 |
0.1519 |
| 121 |
CANDIDA SEPSIS |
136 |
0.1516 |
| 122 |
ACUTE LYMPHOCYTIC LEUKAEMIA |
428 |
0.1510 |
| 123 |
ENTEROBACTER INFECTION |
254 |
0.1510 |
| 124 |
APLASTIC ANAEMIA |
789 |
0.1509 |
| 125 |
ANAEMIA HAEMOLYTIC AUTOIMMUNE |
122 |
0.1473 |
| 126 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
1472 |
0.1465 |
| 127 |
MYELOSUPPRESSION |
5266 |
0.1461 |
| 128 |
BONE MARROW FAILURE |
2954 |
0.1452 |
| 129 |
STENOTROPHOMONAS INFECTION |
197 |
0.1452 |
| 130 |
MUCORMYCOSIS |
368 |
0.1415 |
| 131 |
CYTOMEGALOVIRUS TEST POSITIVE |
252 |
0.1413 |
| 132 |
PNEUMONIA FUNGAL |
549 |
0.1390 |
| 133 |
CAPILLARY LEAK SYNDROME |
287 |
0.1387 |
| 134 |
ENTEROCOCCAL INFECTION |
660 |
0.1364 |
| 135 |
GRANULOCYTE COUNT DECREASED |
253 |
0.1363 |
| 136 |
THROMBOTIC MICROANGIOPATHY |
1323 |
0.1356 |
| 137 |
FUNGAEMIA |
213 |
0.1352 |
| 138 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
1292 |
0.1352 |
| 139 |
ESCHERICHIA SEPSIS |
392 |
0.1351 |
| 140 |
ASPERGILLOSIS |
176 |
0.1347 |
| 141 |
LYMPHOPENIA |
1849 |
0.1306 |
| 142 |
THERAPY PARTIAL RESPONDER |
2039 |
0.1306 |
| 143 |
KLEBSIELLA INFECTION |
658 |
0.1300 |
| 144 |
STAPHYLOCOCCAL BACTERAEMIA |
553 |
0.1271 |
| 145 |
FEBRILE INFECTION |
145 |
0.1232 |
| 146 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
923 |
0.1229 |
| 147 |
MICROANGIOPATHY |
115 |
0.1223 |
| 148 |
MANTLE CELL LYMPHOMA |
186 |
0.1221 |
| 149 |
HYPOFIBRINOGENAEMIA |
119 |
0.1200 |
| 150 |
TUMOUR NECROSIS |
126 |
0.1192 |
| 151 |
LUPUS NEPHRITIS |
223 |
0.1191 |
| 152 |
STRONGYLOIDIASIS |
192 |
0.1187 |
| 153 |
PERIPHERAL SENSORY NEUROPATHY |
689 |
0.1178 |
| 154 |
DILATED CARDIOMYOPATHY |
119 |
0.1177 |
| 155 |
GASTROINTESTINAL TOXICITY |
562 |
0.1169 |
| 156 |
HISTIOCYTOSIS HAEMATOPHAGIC |
346 |
0.1164 |
| 157 |
SUBCLAVIAN VEIN THROMBOSIS |
132 |
0.1159 |
| 158 |
LEUKOENCEPHALOPATHY |
430 |
0.1153 |
| 159 |
GENE MUTATION |
228 |
0.1151 |
| 160 |
STAPHYLOCOCCAL SEPSIS |
567 |
0.1147 |
| 161 |
BLOOD CULTURE POSITIVE |
342 |
0.1141 |
| 162 |
CYTOGENETIC ABNORMALITY |
128 |
0.1134 |
| 163 |
HEPATITIS E |
178 |
0.1127 |
| 164 |
RHINOVIRUS INFECTION |
438 |
0.1124 |
| 165 |
PLASMACYTOMA |
209 |
0.1122 |
| 166 |
PNEUMONIA KLEBSIELLA |
206 |
0.1120 |
| 167 |
T-CELL LYMPHOMA |
128 |
0.1117 |
| 168 |
MYELOPATHY |
210 |
0.1105 |
| 169 |
CYTOMEGALOVIRUS COLITIS |
253 |
0.1099 |
| 170 |
BACTERAEMIA |
1305 |
0.1098 |
| 171 |
PANCYTOPENIA |
6116 |
0.1093 |
| 172 |
ACQUIRED GENE MUTATION |
141 |
0.1076 |
| 173 |
BRAIN ABSCESS |
272 |
0.1074 |
| 174 |
NEUROTOXICITY |
1856 |
0.1058 |
| 175 |
PNEUMOMEDIASTINUM |
191 |
0.1056 |
| 176 |
NEUTROPENIA |
14289 |
0.1050 |
| 177 |
PLASMA CELL MYELOMA RECURRENT |
341 |
0.1049 |
| 178 |
PNEUMATOSIS INTESTINALIS |
299 |
0.1047 |
| 179 |
CLOSTRIDIUM DIFFICILE COLITIS |
1109 |
0.1045 |
| 180 |
HERPES SIMPLEX |
668 |
0.1027 |
| 181 |
SOFT TISSUE INFECTION |
187 |
0.1021 |
| 182 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
349 |
0.1017 |
| 183 |
PULMONARY TOXICITY |
717 |
0.1013 |
| 184 |
B-CELL LYMPHOMA |
344 |
0.1012 |
| 185 |
B-LYMPHOCYTE COUNT DECREASED |
136 |
0.0999 |
| 186 |
LEFT VENTRICULAR DYSFUNCTION |
665 |
0.0992 |
| 187 |
DISEASE PROGRESSION |
11684 |
0.0986 |
| 188 |
OTOTOXICITY |
179 |
0.0967 |
| 189 |
CLOSTRIDIUM COLITIS |
117 |
0.0964 |
| 190 |
NOCARDIOSIS |
241 |
0.0941 |
| 191 |
FANCONI SYNDROME |
132 |
0.0933 |
| 192 |
LYMPHOPROLIFERATIVE DISORDER |
274 |
0.0932 |
| 193 |
PLATELET TRANSFUSION |
120 |
0.0932 |
| 194 |
PERIPHERAL SENSORIMOTOR NEUROPATHY |
117 |
0.0931 |
| 195 |
NEUTROPHIL COUNT DECREASED |
3790 |
0.0929 |
| 196 |
EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED |
115 |
0.0923 |
| 197 |
THROMBOCYTOPENIA |
10306 |
0.0921 |
| 198 |
PSEUDOMONAS INFECTION |
780 |
0.0909 |
| 199 |
SEPTIC SHOCK |
3948 |
0.0906 |
| 200 |
STEROID DIABETES |
136 |
0.0906 |
| 201 |
GASTROENTERITIS NOROVIRUS |
117 |
0.0880 |
| 202 |
NEUTROPHIL COUNT ABNORMAL |
247 |
0.0873 |
| 203 |
MENINGITIS CRYPTOCOCCAL |
152 |
0.0869 |
| 204 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
2457 |
0.0867 |
| 205 |
METASTASES TO MENINGES |
195 |
0.0857 |
| 206 |
NEPHROPATHY TOXIC |
932 |
0.0829 |
| 207 |
JUGULAR VEIN THROMBOSIS |
147 |
0.0825 |
| 208 |
LEUKOPENIA |
4128 |
0.0824 |
| 209 |
OSTEOLYSIS |
167 |
0.0816 |
| 210 |
PNEUMONIA PSEUDOMONAL |
123 |
0.0801 |
| 211 |
VENTRICULAR HYPOKINESIA |
257 |
0.0799 |
| 212 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
1267 |
0.0799 |
| 213 |
POLYNEUROPATHY |
943 |
0.0787 |
| 214 |
NEUROLOGICAL DECOMPENSATION |
182 |
0.0786 |
| 215 |
CARDIAC DYSFUNCTION |
291 |
0.0781 |
| 216 |
SKIN TOXICITY |
441 |
0.0780 |
| 217 |
HYPOALBUMINAEMIA |
605 |
0.0777 |
| 218 |
POLYOMAVIRUS-ASSOCIATED NEPHROPATHY |
182 |
0.0776 |
| 219 |
CHRONIC LYMPHOCYTIC LEUKAEMIA |
366 |
0.0771 |
| 220 |
PULMONARY ALVEOLAR HAEMORRHAGE |
432 |
0.0769 |
| 221 |
AGRANULOCYTOSIS |
1422 |
0.0764 |
| 222 |
VENOUS THROMBOSIS |
293 |
0.0746 |
| 223 |
ORGANISING PNEUMONIA |
369 |
0.0744 |
| 224 |
BONE MARROW TRANSPLANT |
141 |
0.0743 |
| 225 |
LUNG CONSOLIDATION |
208 |
0.0743 |
| 226 |
TRANSPLANT DYSFUNCTION |
132 |
0.0739 |
| 227 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
1301 |
0.0735 |
| 228 |
OPPORTUNISTIC INFECTION |
136 |
0.0735 |
| 229 |
OESOPHAGEAL CANDIDIASIS |
293 |
0.0735 |
| 230 |
EJECTION FRACTION DECREASED |
1138 |
0.0732 |
| 231 |
BONE MARROW DISORDER |
221 |
0.0731 |
| 232 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
194 |
0.0729 |
| 233 |
DEVICE RELATED SEPSIS |
146 |
0.0725 |
| 234 |
RECURRENT CANCER |
295 |
0.0723 |
| 235 |
LUNG INFILTRATION |
637 |
0.0720 |
| 236 |
MULTIPLE-DRUG RESISTANCE |
223 |
0.0718 |
| 237 |
VENA CAVA THROMBOSIS |
119 |
0.0716 |
| 238 |
HEPATOSPLENOMEGALY |
183 |
0.0712 |
| 239 |
LYMPHOCYTE COUNT DECREASED |
1260 |
0.0712 |
| 240 |
ESCHERICHIA INFECTION |
584 |
0.0709 |
| 241 |
HYPOPROTEINAEMIA |
133 |
0.0700 |
| 242 |
BREAST CANCER RECURRENT |
220 |
0.0696 |
| 243 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
266 |
0.0696 |
| 244 |
CARDIOMYOPATHY |
1022 |
0.0691 |
| 245 |
PARAPARESIS |
122 |
0.0684 |
| 246 |
METASTASIS |
488 |
0.0683 |
| 247 |
NEOPLASM PROGRESSION |
2350 |
0.0675 |
| 248 |
PLASMA CELL MYELOMA |
2630 |
0.0673 |
| 249 |
AMYLOIDOSIS |
116 |
0.0672 |
| 250 |
HYPERBILIRUBINAEMIA |
696 |
0.0671 |
| 251 |
SEPSIS |
7492 |
0.0671 |
| 252 |
ENCEPHALITIS |
459 |
0.0663 |
| 253 |
ENCEPHALOPATHY |
1626 |
0.0661 |
| 254 |
PULMONARY HAEMORRHAGE |
507 |
0.0648 |
| 255 |
RENAL TUBULAR DISORDER |
181 |
0.0643 |
| 256 |
ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS |
159 |
0.0643 |
| 257 |
PNEUMONIA VIRAL |
205 |
0.0642 |
| 258 |
BLOOD IMMUNOGLOBULIN G DECREASED |
159 |
0.0641 |
| 259 |
CONGESTIVE CARDIOMYOPATHY |
267 |
0.0640 |
| 260 |
BACTERIAL INFECTION |
1189 |
0.0637 |
| 261 |
EMPYEMA |
126 |
0.0633 |
| 262 |
LYMPHOCYTOSIS |
136 |
0.0631 |
| 263 |
VENTRICULAR DYSFUNCTION |
162 |
0.0624 |
| 264 |
METASTATIC MALIGNANT MELANOMA |
143 |
0.0622 |
| 265 |
DIABETES INSIPIDUS |
149 |
0.0618 |
| 266 |
HEPATOTOXICITY |
1359 |
0.0610 |
| 267 |
LYMPHADENOPATHY MEDIASTINAL |
116 |
0.0605 |
| 268 |
PNEUMONIA STAPHYLOCOCCAL |
119 |
0.0603 |
| 269 |
HYPERTRANSAMINASAEMIA |
418 |
0.0600 |
| 270 |
METASTASES TO LUNG |
690 |
0.0597 |
| 271 |
METASTASES TO LYMPH NODES |
403 |
0.0597 |
| 272 |
ENTERITIS |
376 |
0.0587 |
| 273 |
STAPHYLOCOCCUS TEST POSITIVE |
123 |
0.0583 |
| 274 |
GROWTH RETARDATION |
171 |
0.0580 |
| 275 |
PNEUMONITIS |
1575 |
0.0578 |
| 276 |
CUSHINGOID |
184 |
0.0573 |
| 277 |
INVASIVE DUCTAL BREAST CARCINOMA |
155 |
0.0570 |
| 278 |
LYMPHOMA |
875 |
0.0566 |
| 279 |
HYPOPHOSPHATAEMIA |
417 |
0.0564 |
| 280 |
GUILLAIN-BARRE SYNDROME |
271 |
0.0560 |
| 281 |
OLIGOHYDRAMNIOS |
186 |
0.0557 |
| 282 |
COVID-19 PNEUMONIA |
655 |
0.0554 |
| 283 |
CLOSTRIDIAL INFECTION |
187 |
0.0552 |
| 284 |
ENTEROCOLITIS |
319 |
0.0552 |
| 285 |
GRANULOCYTOPENIA |
311 |
0.0545 |
| 286 |
RESPIRATORY FAILURE |
3974 |
0.0544 |
| 287 |
BRAIN OEDEMA |
687 |
0.0543 |
| 288 |
HAEMOLYTIC URAEMIC SYNDROME |
125 |
0.0539 |
| 289 |
CANDIDA INFECTION |
902 |
0.0534 |
| 290 |
PNEUMONIA BACTERIAL |
489 |
0.0532 |
| 291 |
BRAIN HERNIATION |
158 |
0.0528 |
| 292 |
IMMUNE THROMBOCYTOPENIA |
240 |
0.0524 |
| 293 |
CANDIDIASIS |
210 |
0.0523 |
| 294 |
METASTASES TO PERITONEUM |
132 |
0.0522 |
| 295 |
CLOSTRIDIUM TEST POSITIVE |
115 |
0.0521 |
| 296 |
ILEUS PARALYTIC |
232 |
0.0519 |
| 297 |
EMBOLISM |
430 |
0.0517 |
| 298 |
EMBOLISM VENOUS |
157 |
0.0517 |
| 299 |
HYPERURICAEMIA |
212 |
0.0515 |
| 300 |
HYDROCEPHALUS |
281 |
0.0515 |
| 301 |
TUMOUR HAEMORRHAGE |
147 |
0.0515 |
| 302 |
PSYCHOLOGICAL TRAUMA |
437 |
0.0506 |
| 303 |
LEFT VENTRICULAR FAILURE |
174 |
0.0505 |
| 304 |
MULTI-ORGAN FAILURE |
869 |
0.0502 |
| 305 |
APLASIA PURE RED CELL |
172 |
0.0499 |
| 306 |
ESCHERICHIA URINARY TRACT INFECTION |
211 |
0.0496 |
| 307 |
METASTASES TO LIVER |
871 |
0.0495 |
| 308 |
DISSEMINATED INTRAVASCULAR COAGULATION |
693 |
0.0492 |
| 309 |
HYPERTRIGLYCERIDAEMIA |
287 |
0.0490 |
| 310 |
WHITE BLOOD CELL COUNT DECREASED |
5312 |
0.0490 |
| 311 |
PORTAL HYPERTENSION |
149 |
0.0483 |
| 312 |
MALIGNANT NEOPLASM PROGRESSION |
4940 |
0.0482 |
| 313 |
DISEASE RECURRENCE |
2289 |
0.0481 |
| 314 |
SUSPECTED OFF LABEL USE |
217 |
0.0480 |
| 315 |
ATELECTASIS |
462 |
0.0478 |
| 316 |
DRUG RESISTANCE |
1224 |
0.0476 |
| 317 |
DIASTOLIC DYSFUNCTION |
147 |
0.0476 |
| 318 |
BONE LESION |
171 |
0.0474 |
| 319 |
HYPERPYREXIA |
200 |
0.0472 |
| 320 |
LUNG OPACITY |
124 |
0.0470 |
| 321 |
METASTASES TO BONE |
772 |
0.0470 |
| 322 |
DEVICE RELATED INFECTION |
722 |
0.0469 |
| 323 |
FOETAL GROWTH RESTRICTION |
285 |
0.0468 |
| 324 |
THROMBOTIC THROMBOCYTOPENIC PURPURA |
165 |
0.0468 |
| 325 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
604 |
0.0468 |
| 326 |
GASTROINTESTINAL NECROSIS |
135 |
0.0463 |
| 327 |
NECROSIS |
255 |
0.0458 |
| 328 |
ACUTE HEPATIC FAILURE |
626 |
0.0458 |
| 329 |
SQUAMOUS CELL CARCINOMA OF SKIN |
276 |
0.0457 |
| 330 |
IMMUNOSUPPRESSION |
403 |
0.0456 |
| 331 |
ACUTE PULMONARY OEDEMA |
256 |
0.0456 |
| 332 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
466 |
0.0453 |
| 333 |
NEPHROTIC SYNDROME |
311 |
0.0453 |
| 334 |
INTERSTITIAL LUNG DISEASE |
2187 |
0.0451 |
| 335 |
ANAEMIA |
8594 |
0.0450 |
| 336 |
METASTASES TO SPINE |
150 |
0.0446 |
| 337 |
NEUROPATHY PERIPHERAL |
4206 |
0.0442 |
| 338 |
EXTRAVASATION |
181 |
0.0440 |
| 339 |
PARAPLEGIA |
127 |
0.0440 |
| 340 |
HYPOXIA |
1521 |
0.0431 |
| 341 |
PLATELET COUNT DECREASED |
4599 |
0.0431 |
| 342 |
INFECTION |
6245 |
0.0431 |
| 343 |
TOXIC ENCEPHALOPATHY |
217 |
0.0428 |
| 344 |
VASCULAR DEVICE INFECTION |
194 |
0.0427 |
| 345 |
CACHEXIA |
219 |
0.0425 |
| 346 |
HEPATIC LESION |
184 |
0.0425 |
| 347 |
NECROTISING FASCIITIS |
150 |
0.0425 |
| 348 |
BREAST CANCER METASTATIC |
455 |
0.0423 |
| 349 |
HEPATIC NECROSIS |
159 |
0.0422 |
| 350 |
HEPATIC FAILURE |
1272 |
0.0421 |
| 351 |
RESPIRATORY SYMPTOM |
119 |
0.0418 |
| 352 |
INTESTINAL PERFORATION |
468 |
0.0417 |
| 353 |
CHRONIC SINUSITIS |
156 |
0.0415 |
| 354 |
SPLENOMEGALY |
486 |
0.0414 |
| 355 |
ASCITES |
1219 |
0.0414 |
| 356 |
TRANSAMINASES INCREASED |
919 |
0.0413 |
| 357 |
LIVER ABSCESS |
134 |
0.0413 |
| 358 |
LUNG ADENOCARCINOMA |
124 |
0.0412 |
| 359 |
STAPHYLOCOCCAL INFECTION |
1345 |
0.0407 |
| 360 |
NEUROLOGICAL SYMPTOM |
233 |
0.0407 |
| 361 |
THERAPY NON-RESPONDER |
1828 |
0.0406 |
| 362 |
WHITE BLOOD CELL COUNT ABNORMAL |
258 |
0.0404 |
| 363 |
LUNG INFECTION |
625 |
0.0402 |
| 364 |
PLEURAL EFFUSION |
2431 |
0.0399 |
| 365 |
CARDIAC FAILURE ACUTE |
266 |
0.0399 |
| 366 |
CHRONIC MYELOID LEUKAEMIA |
184 |
0.0398 |
| 367 |
FIBROSIS |
122 |
0.0396 |
| 368 |
LYMPHADENOPATHY |
1403 |
0.0396 |
| 369 |
PERICARDIAL EFFUSION |
916 |
0.0396 |
| 370 |
BLOOD BILIRUBIN INCREASED |
1067 |
0.0395 |
| 371 |
HEPATIC FUNCTION ABNORMAL |
1471 |
0.0394 |
| 372 |
PRODUCT USE IN UNAPPROVED INDICATION |
9754 |
0.0393 |
| 373 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
339 |
0.0389 |
| 374 |
SERUM FERRITIN INCREASED |
204 |
0.0386 |
| 375 |
HYPERVOLAEMIA |
191 |
0.0386 |
| 376 |
OESOPHAGITIS |
417 |
0.0381 |
| 377 |
RESPIRATORY DISTRESS |
1050 |
0.0380 |
| 378 |
HERPES VIRUS INFECTION |
219 |
0.0380 |
| 379 |
HAEMOGLOBIN ABNORMAL |
243 |
0.0377 |
| 380 |
DYSAESTHESIA |
115 |
0.0375 |
| 381 |
HAIR DISORDER |
308 |
0.0373 |
| 382 |
STOMATITIS |
2265 |
0.0373 |
| 383 |
HYPOKALAEMIA |
1723 |
0.0373 |
| 384 |
HEPATOMEGALY |
364 |
0.0370 |
| 385 |
GENERALISED OEDEMA |
457 |
0.0369 |
| 386 |
THROMBOPHLEBITIS |
129 |
0.0368 |
| 387 |
ARTHRITIS BACTERIAL |
150 |
0.0365 |
| 388 |
MENINGITIS |
242 |
0.0362 |
| 389 |
ILEUS |
449 |
0.0361 |
| 390 |
TRANSPLANT REJECTION |
287 |
0.0358 |
| 391 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
832 |
0.0357 |
| 392 |
ELECTROLYTE IMBALANCE |
412 |
0.0354 |
| 393 |
ACUTE RESPIRATORY FAILURE |
676 |
0.0351 |
| 394 |
PYREXIA |
12159 |
0.0351 |
| 395 |
PULMONARY TUBERCULOSIS |
150 |
0.0351 |
| 396 |
HAEMOLYTIC ANAEMIA |
314 |
0.0350 |
| 397 |
ENDOCARDITIS |
179 |
0.0349 |
| 398 |
CARDIAC TAMPONADE |
165 |
0.0347 |
| 399 |
MYOCARDITIS |
394 |
0.0343 |
| 400 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1883 |
0.0343 |
| 401 |
HYDRONEPHROSIS |
256 |
0.0342 |
| 402 |
CARDIOPULMONARY FAILURE |
133 |
0.0341 |
| 403 |
SQUAMOUS CELL CARCINOMA |
320 |
0.0340 |
| 404 |
INTRACRANIAL PRESSURE INCREASED |
189 |
0.0339 |
| 405 |
ORAL CANDIDIASIS |
446 |
0.0338 |
| 406 |
CLOSTRIDIUM DIFFICILE INFECTION |
739 |
0.0338 |
| 407 |
COLITIS |
1278 |
0.0337 |
| 408 |
GASTROINTESTINAL PERFORATION |
140 |
0.0336 |
| 409 |
PROTEINURIA |
638 |
0.0335 |
| 410 |
PNEUMOTHORAX |
531 |
0.0335 |
| 411 |
ADRENAL INSUFFICIENCY |
406 |
0.0334 |
| 412 |
HAEMORRHAGE INTRACRANIAL |
500 |
0.0334 |
| 413 |
FUNGAL INFECTION |
1114 |
0.0334 |
| 414 |
ALANINE AMINOTRANSFERASE INCREASED |
2045 |
0.0333 |
| 415 |
DRUG TOXICITY |
452 |
0.0331 |
| 416 |
NEOPLASM |
381 |
0.0331 |
| 417 |
HEPATIC CYTOLYSIS |
421 |
0.0330 |
| 418 |
PERFORMANCE STATUS DECREASED |
154 |
0.0330 |
| 419 |
HAEMATOCRIT DECREASED |
654 |
0.0329 |
| 420 |
HAEMOLYSIS |
252 |
0.0326 |
| 421 |
HEMIPARESIS |
552 |
0.0326 |
| 422 |
SINUS TACHYCARDIA |
457 |
0.0322 |
| 423 |
C-REACTIVE PROTEIN INCREASED |
1164 |
0.0320 |
| 424 |
LUNG NEOPLASM |
136 |
0.0318 |
| 425 |
LARGE INTESTINE PERFORATION |
221 |
0.0318 |
| 426 |
HAEMODYNAMIC INSTABILITY |
242 |
0.0317 |
| 427 |
PATHOLOGICAL FRACTURE |
160 |
0.0315 |
| 428 |
TACHYPNOEA |
428 |
0.0314 |
| 429 |
COAGULOPATHY |
524 |
0.0314 |
| 430 |
UROSEPSIS |
289 |
0.0313 |
| 431 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
156 |
0.0313 |
| 432 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1661 |
0.0312 |
| 433 |
HYPOCALCAEMIA |
591 |
0.0312 |
| 434 |
MALNUTRITION |
349 |
0.0312 |
| 435 |
STREPTOCOCCAL INFECTION |
173 |
0.0311 |
| 436 |
CARDIAC FAILURE |
2489 |
0.0310 |
| 437 |
ABDOMINAL ABSCESS |
137 |
0.0310 |
| 438 |
MADAROSIS |
358 |
0.0308 |
| 439 |
SKIN NECROSIS |
160 |
0.0308 |
| 440 |
METASTATIC NEOPLASM |
133 |
0.0308 |
| 441 |
FAILURE TO THRIVE |
159 |
0.0306 |
| 442 |
HAIR COLOUR CHANGES |
379 |
0.0304 |
| 443 |
HYPERNATRAEMIA |
151 |
0.0303 |
| 444 |
RESPIRATORY TRACT INFECTION |
784 |
0.0301 |
| 445 |
MENINGITIS ASEPTIC |
134 |
0.0298 |
| 446 |
METABOLIC DISORDER |
173 |
0.0298 |
| 447 |
MYOSITIS |
267 |
0.0297 |
| 448 |
CARDIAC FAILURE CHRONIC |
126 |
0.0295 |
| 449 |
HYPERCALCAEMIA |
365 |
0.0295 |
| 450 |
ERYSIPELAS |
148 |
0.0294 |
| 451 |
SKIN INFECTION |
330 |
0.0294 |
| 452 |
BLOOD DISORDER |
235 |
0.0293 |
| 453 |
CHOLESTASIS |
563 |
0.0293 |
| 454 |
CEREBRAL ISCHAEMIA |
150 |
0.0291 |
| 455 |
RED CELL DISTRIBUTION WIDTH INCREASED |
121 |
0.0291 |
| 456 |
PROCTALGIA |
187 |
0.0291 |
| 457 |
VASCULITIS |
338 |
0.0290 |
| 458 |
OLIGURIA |
180 |
0.0290 |
| 459 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
176 |
0.0289 |
| 460 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
638 |
0.0288 |
| 461 |
PARTIAL SEIZURES |
150 |
0.0286 |
| 462 |
PAPILLOEDEMA |
129 |
0.0285 |
| 463 |
ODYNOPHAGIA |
170 |
0.0285 |
| 464 |
LEUKOCYTOSIS |
513 |
0.0283 |
| 465 |
HYPOMAGNESAEMIA |
391 |
0.0281 |
| 466 |
HYPERGLYCAEMIA |
1023 |
0.0280 |
| 467 |
SARCOIDOSIS |
133 |
0.0280 |
| 468 |
MENTAL STATUS CHANGES |
776 |
0.0279 |
| 469 |
RETINAL HAEMORRHAGE |
199 |
0.0279 |
| 470 |
TROPONIN INCREASED |
212 |
0.0278 |
| 471 |
GASTROINTESTINAL INFLAMMATION |
218 |
0.0278 |
| 472 |
INFLAMMATORY MARKER INCREASED |
137 |
0.0276 |
| 473 |
ABDOMINAL TENDERNESS |
137 |
0.0276 |
| 474 |
PYELONEPHRITIS |
238 |
0.0274 |
| 475 |
LEUKAEMIA |
259 |
0.0274 |
| 476 |
HAIR TEXTURE ABNORMAL |
367 |
0.0274 |
| 477 |
MULTIPLE MYELOMA |
127 |
0.0272 |
| 478 |
BLOOD ALBUMIN DECREASED |
216 |
0.0272 |
| 479 |
ATAXIA |
321 |
0.0270 |
| 480 |
PATHOGEN RESISTANCE |
245 |
0.0269 |
| 481 |
HAEMATURIA |
918 |
0.0268 |
| 482 |
NEUTROPHIL COUNT INCREASED |
274 |
0.0267 |
| 483 |
MITRAL VALVE INCOMPETENCE |
302 |
0.0267 |
| 484 |
DEEP VEIN THROMBOSIS |
1727 |
0.0266 |
| 485 |
BRONCHIECTASIS |
179 |
0.0265 |
| 486 |
LOW BIRTH WEIGHT BABY |
210 |
0.0264 |
| 487 |
DRUG-INDUCED LIVER INJURY |
825 |
0.0263 |
| 488 |
PLATELET COUNT ABNORMAL |
158 |
0.0261 |
| 489 |
OFF LABEL USE |
22823 |
0.0260 |
| 490 |
HYPONATRAEMIA |
1467 |
0.0260 |
| 491 |
PNEUMONIA |
8384 |
0.0259 |
| 492 |
PULMONARY EMBOLISM |
2445 |
0.0257 |
| 493 |
CARDIOGENIC SHOCK |
367 |
0.0256 |
| 494 |
STRESS CARDIOMYOPATHY |
148 |
0.0254 |
| 495 |
SHOCK HAEMORRHAGIC |
206 |
0.0253 |
| 496 |
BASAL CELL CARCINOMA |
394 |
0.0252 |
| 497 |
MYOPATHY |
218 |
0.0252 |
| 498 |
HAEMOGLOBIN DECREASED |
2586 |
0.0252 |
| 499 |
STATUS EPILEPTICUS |
284 |
0.0251 |
| 500 |
HEPATIC ENCEPHALOPATHY |
234 |
0.0251 |
| 501 |
ACUTE KIDNEY INJURY |
3830 |
0.0250 |
| 502 |
ANGIOPATHY |
140 |
0.0250 |
| 503 |
SMALL INTESTINAL OBSTRUCTION |
307 |
0.0249 |
| 504 |
PULMONARY FIBROSIS |
476 |
0.0248 |
| 505 |
GASTROINTESTINAL INFECTION |
222 |
0.0247 |
| 506 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
125 |
0.0247 |
| 507 |
LIVER INJURY |
605 |
0.0246 |
| 508 |
HERPES ZOSTER |
1415 |
0.0246 |
| 509 |
RALES |
143 |
0.0246 |
| 510 |
ATRIAL FLUTTER |
196 |
0.0245 |
| 511 |
OSTEONECROSIS |
806 |
0.0245 |
| 512 |
PETECHIAE |
255 |
0.0244 |
| 513 |
HYPOVOLAEMIC SHOCK |
117 |
0.0244 |
| 514 |
HEPATITIS |
620 |
0.0242 |
| 515 |
TOXIC EPIDERMAL NECROLYSIS |
364 |
0.0239 |
| 516 |
BLOOD LACTIC ACID INCREASED |
126 |
0.0239 |
| 517 |
ORAL DISORDER |
175 |
0.0238 |
| 518 |
NO THERAPEUTIC RESPONSE |
290 |
0.0238 |
| 519 |
CHOLECYSTITIS |
283 |
0.0237 |
| 520 |
ANAL ABSCESS |
128 |
0.0237 |
| 521 |
PULMONARY HYPERTENSION |
494 |
0.0237 |
| 522 |
RENAL CELL CARCINOMA |
116 |
0.0237 |
| 523 |
HEPATOCELLULAR INJURY |
336 |
0.0237 |
| 524 |
HOSPICE CARE |
234 |
0.0237 |
| 525 |
PREMATURE BABY |
710 |
0.0236 |
| 526 |
FACIAL PARALYSIS |
200 |
0.0234 |
| 527 |
HYPOVOLAEMIA |
137 |
0.0234 |
| 528 |
HEPATITIS CHOLESTATIC |
141 |
0.0234 |
| 529 |
VIRAL INFECTION |
770 |
0.0231 |
| 530 |
PULMONARY ARTERIAL HYPERTENSION |
334 |
0.0230 |
| 531 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
571 |
0.0230 |
| 532 |
CHOLECYSTITIS ACUTE |
130 |
0.0229 |
| 533 |
INTENTIONAL PRODUCT USE ISSUE |
2008 |
0.0229 |
| 534 |
HAEMODIALYSIS |
192 |
0.0228 |
| 535 |
NERVOUS SYSTEM DISORDER |
711 |
0.0228 |
| 536 |
APHASIA |
684 |
0.0226 |
| 537 |
RENAL TUBULAR NECROSIS |
222 |
0.0226 |
| 538 |
PULMONARY MASS |
336 |
0.0225 |
| 539 |
ACUTE CORONARY SYNDROME |
186 |
0.0224 |
| 540 |
TRICUSPID VALVE INCOMPETENCE |
177 |
0.0223 |
| 541 |
HEMIPLEGIA |
185 |
0.0222 |
| 542 |
TOXIC SKIN ERUPTION |
219 |
0.0217 |
| 543 |
ATRIAL FIBRILLATION |
2117 |
0.0217 |
| 544 |
SUBDURAL HAEMATOMA |
311 |
0.0217 |
| 545 |
RENAL IMPAIRMENT |
1819 |
0.0216 |
| 546 |
APPENDICITIS |
202 |
0.0216 |
| 547 |
CELLULITIS |
1083 |
0.0215 |
| 548 |
DERMATITIS BULLOUS |
155 |
0.0214 |
| 549 |
GASTROENTERITIS |
311 |
0.0213 |
| 550 |
MOUTH ULCERATION |
448 |
0.0212 |
| 551 |
BRAIN NEOPLASM |
195 |
0.0212 |
| 552 |
CORONAVIRUS INFECTION |
139 |
0.0210 |
| 553 |
ACIDOSIS |
159 |
0.0208 |
| 554 |
BODY TEMPERATURE INCREASED |
423 |
0.0207 |
| 555 |
TRANSFUSION |
217 |
0.0207 |
| 556 |
LYMPHOEDEMA |
142 |
0.0205 |
| 557 |
TREATMENT FAILURE |
1697 |
0.0205 |
| 558 |
SUPRAVENTRICULAR TACHYCARDIA |
196 |
0.0205 |
| 559 |
RENAL FAILURE |
2718 |
0.0204 |
| 560 |
TUBULOINTERSTITIAL NEPHRITIS |
383 |
0.0204 |
| 561 |
SKIN HYPERPIGMENTATION |
175 |
0.0203 |
| 562 |
PULMONARY OEDEMA |
908 |
0.0203 |
| 563 |
RASH MACULO-PAPULAR |
451 |
0.0203 |
| 564 |
HYPOPHAGIA |
518 |
0.0202 |
| 565 |
PURPURA |
179 |
0.0202 |
| 566 |
LIPASE INCREASED |
155 |
0.0202 |
| 567 |
HEPATIC STEATOSIS |
375 |
0.0201 |
| 568 |
SUBARACHNOID HAEMORRHAGE |
205 |
0.0201 |
| 569 |
END STAGE RENAL DISEASE |
366 |
0.0200 |
| 570 |
SKIN MASS |
133 |
0.0199 |
| 571 |
PROTHROMBIN TIME PROLONGED |
119 |
0.0199 |
| 572 |
MASS |
277 |
0.0198 |
| 573 |
PREMATURE DELIVERY |
315 |
0.0198 |
| 574 |
MALIGNANT MELANOMA |
264 |
0.0197 |
| 575 |
SUDDEN DEATH |
208 |
0.0196 |
| 576 |
HYPERTHERMIA |
150 |
0.0196 |
| 577 |
RIGHT VENTRICULAR FAILURE |
137 |
0.0195 |
| 578 |
LUNG DISORDER |
958 |
0.0195 |
| 579 |
SKIN LESION |
536 |
0.0195 |
| 580 |
IMMUNODEFICIENCY |
290 |
0.0194 |
| 581 |
BLOOD CREATININE INCREASED |
1265 |
0.0194 |
| 582 |
GENERAL PHYSICAL HEALTH DETERIORATION |
2211 |
0.0191 |
| 583 |
CEREBRAL HAEMORRHAGE |
684 |
0.0191 |
| 584 |
PANCREATITIS ACUTE |
427 |
0.0190 |
| 585 |
ANURIA |
162 |
0.0188 |
| 586 |
TACHYCARDIA |
1671 |
0.0188 |
| 587 |
BONE PAIN |
1101 |
0.0188 |
| 588 |
URINE OUTPUT DECREASED |
164 |
0.0187 |
| 589 |
SHOCK |
430 |
0.0187 |
| 590 |
GENERALISED TONIC-CLONIC SEIZURE |
309 |
0.0187 |
| 591 |
RENAL FAILURE ACUTE |
789 |
0.0186 |
| 592 |
CARDIOMEGALY |
222 |
0.0180 |
| 593 |
HYPOTENSION |
3606 |
0.0180 |
| 594 |
HYPOTHYROIDISM |
572 |
0.0179 |
| 595 |
HEPATITIS ACUTE |
115 |
0.0177 |
| 596 |
CIRCULATORY COLLAPSE |
295 |
0.0173 |
| 597 |
ANOREXIA |
223 |
0.0173 |
| 598 |
GRAND MAL CONVULSION |
159 |
0.0172 |
| 599 |
UPPER RESPIRATORY TRACT INFECTION |
792 |
0.0171 |
| 600 |
DECUBITUS ULCER |
139 |
0.0170 |
| 601 |
TOXICITY TO VARIOUS AGENTS |
2875 |
0.0170 |
| 602 |
INFUSION RELATED REACTION |
1128 |
0.0170 |
| 603 |
OEDEMA |
914 |
0.0168 |
| 604 |
ECCHYMOSIS |
115 |
0.0168 |
| 605 |
EOSINOPHIL COUNT INCREASED |
139 |
0.0167 |
| 606 |
GASTROINTESTINAL DISORDER |
1484 |
0.0165 |
| 607 |
WHITE BLOOD CELL COUNT INCREASED |
633 |
0.0165 |
| 608 |
LIVER DISORDER |
731 |
0.0165 |
| 609 |
ORAL HERPES |
321 |
0.0164 |
| 610 |
RENAL CYST |
130 |
0.0164 |
| 611 |
ABSCESS |
261 |
0.0163 |
| 612 |
JAUNDICE |
440 |
0.0163 |
| 613 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
275 |
0.0163 |
| 614 |
PNEUMONIA ASPIRATION |
407 |
0.0163 |
| 615 |
CEREBRAL INFARCTION |
398 |
0.0163 |
| 616 |
BLOOD UREA INCREASED |
272 |
0.0162 |
| 617 |
COVID-19 |
2845 |
0.0162 |
| 618 |
SENSORY LOSS |
128 |
0.0159 |
| 619 |
RED BLOOD CELL COUNT DECREASED |
454 |
0.0159 |
| 620 |
CHILLS |
1861 |
0.0159 |
| 621 |
ALTERED STATE OF CONSCIOUSNESS |
343 |
0.0158 |
| 622 |
CONVULSION |
904 |
0.0158 |
| 623 |
OSTEONECROSIS OF JAW |
390 |
0.0157 |
| 624 |
SEIZURE |
1811 |
0.0157 |
| 625 |
OBSTRUCTIVE AIRWAYS DISORDER |
173 |
0.0155 |
| 626 |
TENDERNESS |
162 |
0.0155 |
| 627 |
NAIL DISORDER |
136 |
0.0155 |
| 628 |
VOMITING |
7260 |
0.0154 |
| 629 |
RESPIRATORY DISORDER |
460 |
0.0154 |
| 630 |
PERICARDITIS |
258 |
0.0153 |
| 631 |
OSTEOMYELITIS |
278 |
0.0153 |
| 632 |
CENTRAL NERVOUS SYSTEM LESION |
210 |
0.0153 |
| 633 |
DIARRHOEA HAEMORRHAGIC |
142 |
0.0152 |
| 634 |
FULL BLOOD COUNT DECREASED |
306 |
0.0152 |
| 635 |
GASTROINTESTINAL HAEMORRHAGE |
1255 |
0.0150 |
| 636 |
DEHYDRATION |
1983 |
0.0149 |
| 637 |
ISCHAEMIC STROKE |
265 |
0.0148 |
| 638 |
FLUID OVERLOAD |
216 |
0.0148 |
| 639 |
ERYTHEMA MULTIFORME |
138 |
0.0148 |
| 640 |
DERMATITIS |
310 |
0.0148 |
| 641 |
HYPOTONIA |
147 |
0.0147 |
| 642 |
IMPAIRED QUALITY OF LIFE |
211 |
0.0147 |
| 643 |
DEAFNESS |
383 |
0.0146 |
| 644 |
EPILEPSY |
447 |
0.0146 |
| 645 |
ACUTE MYOCARDIAL INFARCTION |
431 |
0.0146 |
| 646 |
MOTOR DYSFUNCTION |
148 |
0.0145 |
| 647 |
ASPIRATION |
159 |
0.0145 |
| 648 |
HICCUPS |
119 |
0.0145 |
| 649 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
572 |
0.0144 |
| 650 |
MYOCARDIAL ISCHAEMIA |
164 |
0.0144 |
| 651 |
HAEMORRHOIDS |
280 |
0.0143 |
| 652 |
ORAL PAIN |
320 |
0.0143 |
| 653 |
PHARYNGITIS |
177 |
0.0143 |
| 654 |
DRUG INTOLERANCE |
1373 |
0.0142 |
| 655 |
HEPATITIS C |
170 |
0.0141 |
| 656 |
RESPIRATORY RATE INCREASED |
125 |
0.0141 |
| 657 |
PERITONITIS |
290 |
0.0140 |
| 658 |
WOUND INFECTION |
153 |
0.0140 |
| 659 |
PULMONARY CONGESTION |
184 |
0.0139 |
| 660 |
BLOOD MAGNESIUM DECREASED |
120 |
0.0139 |
| 661 |
CYSTITIS |
440 |
0.0138 |
| 662 |
HAEMOPTYSIS |
385 |
0.0138 |
| 663 |
PLATELET COUNT INCREASED |
179 |
0.0137 |
| 664 |
SKIN ULCER |
354 |
0.0137 |
| 665 |
GLOMERULAR FILTRATION RATE DECREASED |
168 |
0.0137 |
| 666 |
DRUG ERUPTION |
242 |
0.0136 |
| 667 |
LOWER RESPIRATORY TRACT INFECTION |
620 |
0.0136 |
| 668 |
ABDOMINAL PAIN |
3160 |
0.0136 |
| 669 |
BLOOD SODIUM DECREASED |
256 |
0.0136 |
| 670 |
NODULE |
177 |
0.0135 |
| 671 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
396 |
0.0135 |
| 672 |
REBOUND EFFECT |
152 |
0.0134 |
| 673 |
LIVER FUNCTION TEST ABNORMAL |
390 |
0.0134 |
| 674 |
THERAPEUTIC RESPONSE DECREASED |
812 |
0.0134 |
| 675 |
CARDIAC ARREST |
1104 |
0.0134 |
| 676 |
COGNITIVE DISORDER |
623 |
0.0133 |
| 677 |
DELIRIUM |
462 |
0.0133 |
| 678 |
BLOOD COUNT ABNORMAL |
200 |
0.0132 |
| 679 |
DYSPHAGIA |
1252 |
0.0132 |
| 680 |
BLOOD CALCIUM DECREASED |
148 |
0.0131 |
| 681 |
VENTRICULAR EXTRASYSTOLES |
136 |
0.0131 |
| 682 |
HYPERKALAEMIA |
459 |
0.0131 |
| 683 |
DECREASED APPETITE |
3036 |
0.0131 |
| 684 |
ORTHOSTATIC HYPOTENSION |
227 |
0.0130 |
| 685 |
HAEMATEMESIS |
330 |
0.0130 |
| 686 |
DYSPNOEA EXERTIONAL |
483 |
0.0128 |
| 687 |
NEPHROPATHY |
119 |
0.0127 |
| 688 |
EPISTAXIS |
949 |
0.0127 |
| 689 |
ALOPECIA |
2475 |
0.0126 |
| 690 |
ARRHYTHMIA |
595 |
0.0126 |
| 691 |
SPINAL PAIN |
147 |
0.0125 |
| 692 |
MELAENA |
273 |
0.0124 |
| 693 |
VENTRICULAR TACHYCARDIA |
203 |
0.0123 |
| 694 |
FLANK PAIN |
115 |
0.0123 |
| 695 |
BODY TEMPERATURE DECREASED |
120 |
0.0122 |
| 696 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
866 |
0.0122 |
| 697 |
HAEMORRHAGE |
1269 |
0.0121 |
| 698 |
SKIN REACTION |
170 |
0.0121 |
| 699 |
OBESITY |
192 |
0.0120 |
| 700 |
METABOLIC ACIDOSIS |
385 |
0.0120 |
| 701 |
ASTHENIA |
4507 |
0.0120 |
| 702 |
TOOTH ABSCESS |
122 |
0.0120 |
| 703 |
DIARRHOEA |
7731 |
0.0120 |
| 704 |
NAUSEA |
9357 |
0.0118 |
| 705 |
DYSARTHRIA |
443 |
0.0118 |
| 706 |
PRODUCT USE ISSUE |
2209 |
0.0117 |
| 707 |
CONSTIPATION |
2561 |
0.0117 |
| 708 |
VENTRICULAR FIBRILLATION |
130 |
0.0117 |
| 709 |
GASTRITIS |
305 |
0.0116 |
| 710 |
CONFUSIONAL STATE |
1864 |
0.0115 |
| 711 |
SENSORY DISTURBANCE |
185 |
0.0115 |
| 712 |
DYSURIA |
424 |
0.0115 |
| 713 |
PRODUCTIVE COUGH |
547 |
0.0114 |
| 714 |
HYPOTHERMIA |
116 |
0.0114 |
| 715 |
MUSCULOSKELETAL CHEST PAIN |
177 |
0.0114 |
| 716 |
DISORIENTATION |
453 |
0.0114 |
| 717 |
PALLOR |
311 |
0.0114 |
| 718 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
126 |
0.0114 |
| 719 |
URINARY TRACT INFECTION |
1939 |
0.0114 |
| 720 |
HYPERTENSION |
2403 |
0.0113 |
| 721 |
OSTEOPENIA |
172 |
0.0113 |
| 722 |
LIVER FUNCTION TEST INCREASED |
243 |
0.0113 |
| 723 |
GASTRIC ULCER |
214 |
0.0112 |
| 724 |
OEDEMA PERIPHERAL |
1366 |
0.0112 |
| 725 |
DIALYSIS |
159 |
0.0112 |
| 726 |
FULL BLOOD COUNT ABNORMAL |
118 |
0.0111 |
| 727 |
PANCREATITIS |
589 |
0.0111 |
| 728 |
GASTRIC HAEMORRHAGE |
128 |
0.0111 |
| 729 |
HEPATIC ENZYME INCREASED |
758 |
0.0111 |
| 730 |
NIGHT SWEATS |
358 |
0.0111 |
| 731 |
SYNCOPE |
1111 |
0.0111 |
| 732 |
INFLAMMATION |
565 |
0.0109 |
| 733 |
CARDIAC FAILURE CONGESTIVE |
876 |
0.0109 |
| 734 |
CONDITION AGGRAVATED |
3314 |
0.0109 |
| 735 |
OXYGEN SATURATION DECREASED |
612 |
0.0109 |
| 736 |
MYOCLONUS |
129 |
0.0108 |
| 737 |
DRUG LEVEL INCREASED |
179 |
0.0108 |
| 738 |
THROMBOSIS |
867 |
0.0108 |
| 739 |
HAEMATOMA |
279 |
0.0108 |
| 740 |
MUSCULAR WEAKNESS |
1216 |
0.0107 |
| 741 |
PARALYSIS |
153 |
0.0107 |
| 742 |
DRUG INEFFECTIVE |
14044 |
0.0106 |
| 743 |
DIPLOPIA |
276 |
0.0106 |
| 744 |
APPLICATION SITE PAIN |
234 |
0.0106 |
| 745 |
NEURALGIA |
255 |
0.0105 |
| 746 |
UNRESPONSIVE TO STIMULI |
270 |
0.0105 |
| 747 |
ULCER |
166 |
0.0104 |
| 748 |
BLOOD POTASSIUM DECREASED |
312 |
0.0104 |
| 749 |
DRUG INTERACTION |
1641 |
0.0103 |
| 750 |
LETHARGY |
589 |
0.0102 |
| 751 |
HYPERLIPIDAEMIA |
122 |
0.0102 |
| 752 |
CARDIO-RESPIRATORY ARREST |
424 |
0.0101 |
| 753 |
DIVERTICULITIS |
280 |
0.0101 |
| 754 |
APPLICATION SITE PRURITUS |
229 |
0.0101 |
| 755 |
URINARY INCONTINENCE |
299 |
0.0101 |
| 756 |
DRUG EXPOSURE DURING PREGNANCY |
340 |
0.0100 |
| 757 |
BONE DISORDER |
182 |
0.0100 |
| 758 |
AMENORRHOEA |
175 |
0.0100 |
| 759 |
URINARY RETENTION |
333 |
0.0100 |
| 760 |
ELECTROCARDIOGRAM QT PROLONGED |
358 |
0.0099 |
| 761 |
STEVENS-JOHNSON SYNDROME |
221 |
0.0099 |
| 762 |
EOSINOPHILIA |
174 |
0.0099 |
| 763 |
INTESTINAL OBSTRUCTION |
374 |
0.0099 |
| 764 |
SKIN DISORDER |
330 |
0.0099 |
| 765 |
FOETAL EXPOSURE DURING PREGNANCY |
804 |
0.0099 |
| 766 |
MATERNAL EXPOSURE DURING PREGNANCY |
878 |
0.0098 |
| 767 |
DEATH |
8486 |
0.0098 |
| 768 |
CONJUNCTIVITIS |
182 |
0.0098 |
| 769 |
COMA |
467 |
0.0098 |
| 770 |
BRADYCARDIA |
519 |
0.0098 |
| 771 |
POST PROCEDURAL COMPLICATION |
187 |
0.0097 |
| 772 |
ANAPHYLACTIC REACTION |
538 |
0.0097 |
| 773 |
PRODUCT PRESCRIBING ISSUE |
210 |
0.0096 |
| 774 |
BLINDNESS |
391 |
0.0096 |
| 775 |
HEPATIC CIRRHOSIS |
179 |
0.0095 |
| 776 |
NEOPLASM MALIGNANT |
632 |
0.0095 |
| 777 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
242 |
0.0094 |
| 778 |
FACE OEDEMA |
156 |
0.0092 |
| 779 |
OSTEOPOROSIS |
380 |
0.0092 |
| 780 |
COUGH |
2577 |
0.0092 |
| 781 |
TOOTH INFECTION |
121 |
0.0092 |
| 782 |
HYPERTHYROIDISM |
131 |
0.0090 |
| 783 |
IMMUNE SYSTEM DISORDER |
119 |
0.0090 |
| 784 |
ILL-DEFINED DISORDER |
544 |
0.0089 |
| 785 |
BRONCHOSPASM |
127 |
0.0089 |
| 786 |
TASTE DISORDER |
179 |
0.0088 |
| 787 |
SARS-COV-2 TEST POSITIVE |
116 |
0.0088 |
| 788 |
DYSPNOEA |
4972 |
0.0088 |
| 789 |
RENAL DISORDER |
406 |
0.0087 |
| 790 |
CYANOSIS |
137 |
0.0087 |
| 791 |
HYPOKINESIA |
126 |
0.0087 |
| 792 |
COLON CANCER |
129 |
0.0086 |
| 793 |
APPLICATION SITE ERYTHEMA |
226 |
0.0086 |
| 794 |
GOUT |
151 |
0.0084 |
| 795 |
FATIGUE |
6371 |
0.0082 |
| 796 |
FEEDING DISORDER |
163 |
0.0080 |
| 797 |
BLOOD PRESSURE DECREASED |
529 |
0.0080 |
| 798 |
RECTAL HAEMORRHAGE |
342 |
0.0080 |
| 799 |
CHEST PAIN |
1471 |
0.0079 |
| 800 |
VISUAL ACUITY REDUCED |
262 |
0.0079 |
| 801 |
RHABDOMYOLYSIS |
327 |
0.0078 |
| 802 |
RASH ERYTHEMATOUS |
373 |
0.0078 |
| 803 |
BLOOD PRESSURE SYSTOLIC INCREASED |
150 |
0.0077 |
| 804 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
218 |
0.0076 |
| 805 |
EXPOSURE DURING PREGNANCY |
469 |
0.0075 |
| 806 |
ANGINA PECTORIS |
216 |
0.0075 |
| 807 |
BLISTER |
422 |
0.0075 |
| 808 |
WEIGHT DECREASED |
2097 |
0.0075 |
| 809 |
CARDIOVASCULAR DISORDER |
190 |
0.0075 |
| 810 |
RASH PAPULAR |
167 |
0.0074 |
| 811 |
IMPAIRED HEALING |
244 |
0.0074 |
| 812 |
CHOLELITHIASIS |
242 |
0.0074 |
| 813 |
PAIN IN JAW |
208 |
0.0073 |
| 814 |
LACTIC ACIDOSIS |
236 |
0.0073 |
| 815 |
DIABETES MELLITUS |
551 |
0.0072 |
| 816 |
PARAESTHESIA |
1132 |
0.0072 |
| 817 |
CHEST DISCOMFORT |
736 |
0.0072 |
| 818 |
PRESYNCOPE |
174 |
0.0071 |
| 819 |
OROPHARYNGEAL PAIN |
654 |
0.0071 |
| 820 |
SPEECH DISORDER |
368 |
0.0070 |
| 821 |
ABDOMINAL DISTENSION |
726 |
0.0069 |
| 822 |
EAR PAIN |
135 |
0.0069 |
| 823 |
SPINAL FRACTURE |
139 |
0.0069 |
| 824 |
BACK PAIN |
1591 |
0.0068 |
| 825 |
ANAPHYLACTIC SHOCK |
176 |
0.0068 |
| 826 |
RASH |
2951 |
0.0068 |
| 827 |
SINUSITIS |
689 |
0.0067 |
| 828 |
MYALGIA |
1142 |
0.0067 |
| 829 |
ERYTHEMA |
1378 |
0.0067 |
| 830 |
EATING DISORDER |
140 |
0.0066 |
| 831 |
BLOOD TRIGLYCERIDES INCREASED |
116 |
0.0066 |
| 832 |
LACRIMATION INCREASED |
198 |
0.0065 |
| 833 |
HYPOAESTHESIA |
976 |
0.0065 |
| 834 |
CARDIAC DISORDER |
608 |
0.0065 |
| 835 |
SKIN DISCOLOURATION |
297 |
0.0065 |
| 836 |
CATARACT |
380 |
0.0064 |
| 837 |
POLLAKIURIA |
265 |
0.0063 |
| 838 |
LUNG NEOPLASM MALIGNANT |
261 |
0.0063 |
| 839 |
INTERNATIONAL NORMALISED RATIO INCREASED |
180 |
0.0063 |
| 840 |
INFLUENZA |
704 |
0.0063 |
| 841 |
AGITATION |
450 |
0.0061 |
| 842 |
RHINORRHOEA |
396 |
0.0061 |
| 843 |
ADVERSE EVENT |
562 |
0.0061 |
| 844 |
LABORATORY TEST ABNORMAL |
179 |
0.0061 |
| 845 |
HYPOGLYCAEMIA |
294 |
0.0061 |
| 846 |
CHRONIC KIDNEY DISEASE |
460 |
0.0060 |
| 847 |
FAECES DISCOLOURED |
131 |
0.0060 |
| 848 |
HYPERSENSITIVITY |
1116 |
0.0060 |
| 849 |
BRONCHITIS |
442 |
0.0060 |
| 850 |
TRANSIENT ISCHAEMIC ATTACK |
201 |
0.0060 |
| 851 |
DRUG EFFECT INCOMPLETE |
215 |
0.0059 |
| 852 |
MUSCULOSKELETAL PAIN |
306 |
0.0058 |
| 853 |
HALLUCINATION, VISUAL |
122 |
0.0058 |
| 854 |
HAEMATOCHEZIA |
317 |
0.0057 |
| 855 |
RIB FRACTURE |
117 |
0.0057 |
| 856 |
BREAST CANCER |
529 |
0.0057 |
| 857 |
ABDOMINAL PAIN LOWER |
143 |
0.0056 |
| 858 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
200 |
0.0056 |
| 859 |
LOSS OF CONSCIOUSNESS |
714 |
0.0056 |
| 860 |
FLUID RETENTION |
281 |
0.0055 |
| 861 |
SKIN EXFOLIATION |
462 |
0.0055 |
| 862 |
HEADACHE |
3404 |
0.0054 |
| 863 |
PAIN OF SKIN |
146 |
0.0054 |
| 864 |
RASH PRURITIC |
293 |
0.0054 |
| 865 |
RENAL INJURY |
160 |
0.0054 |
| 866 |
CONTRAINDICATED PRODUCT ADMINISTERED |
163 |
0.0054 |
| 867 |
TREMOR |
887 |
0.0053 |
| 868 |
MOVEMENT DISORDER |
167 |
0.0052 |
| 869 |
DISTURBANCE IN ATTENTION |
280 |
0.0052 |
| 870 |
DISCOMFORT |
313 |
0.0051 |
| 871 |
DIABETIC KETOACIDOSIS |
123 |
0.0051 |
| 872 |
MUSCLE TWITCHING |
118 |
0.0051 |
| 873 |
TREATMENT NONCOMPLIANCE |
279 |
0.0051 |
| 874 |
WHEEZING |
302 |
0.0051 |
| 875 |
PSYCHOTIC DISORDER |
150 |
0.0051 |
| 876 |
MENTAL DISORDER |
220 |
0.0051 |
| 877 |
RESPIRATORY ARREST |
139 |
0.0050 |
| 878 |
TINNITUS |
230 |
0.0050 |
| 879 |
RASH GENERALISED |
129 |
0.0050 |
| 880 |
HEART RATE INCREASED |
484 |
0.0049 |
| 881 |
NECK PAIN |
271 |
0.0048 |
| 882 |
HYPOACUSIS |
207 |
0.0048 |
| 883 |
MALAISE |
2062 |
0.0047 |
| 884 |
DYSPEPSIA |
459 |
0.0047 |
| 885 |
SOMNOLENCE |
935 |
0.0046 |
| 886 |
THROAT TIGHTNESS |
125 |
0.0046 |
| 887 |
DYSSTASIA |
134 |
0.0046 |
| 888 |
PAIN |
2817 |
0.0046 |
| 889 |
PAIN IN EXTREMITY |
1337 |
0.0045 |
| 890 |
ABDOMINAL PAIN UPPER |
932 |
0.0045 |
| 891 |
DYSGEUSIA |
333 |
0.0045 |
| 892 |
THERAPY CESSATION |
230 |
0.0045 |
| 893 |
CEREBROVASCULAR ACCIDENT |
757 |
0.0045 |
| 894 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
232 |
0.0044 |
| 895 |
GASTROOESOPHAGEAL REFLUX DISEASE |
354 |
0.0044 |
| 896 |
GAIT DISTURBANCE |
831 |
0.0043 |
| 897 |
DYSPHONIA |
251 |
0.0043 |
| 898 |
SWELLING FACE |
274 |
0.0042 |
| 899 |
ARTHRALGIA |
1729 |
0.0042 |
| 900 |
FALL |
1376 |
0.0041 |
| 901 |
PALPITATIONS |
481 |
0.0041 |
| 902 |
TYPE 2 DIABETES MELLITUS |
138 |
0.0041 |
| 903 |
CORONARY ARTERY DISEASE |
124 |
0.0041 |
| 904 |
HYPERHIDROSIS |
526 |
0.0041 |
| 905 |
INTENTIONAL DOSE OMISSION |
116 |
0.0041 |
| 906 |
SWELLING |
367 |
0.0039 |
| 907 |
HEAD INJURY |
124 |
0.0039 |
| 908 |
MYOCARDIAL INFARCTION |
682 |
0.0039 |
| 909 |
HALLUCINATION |
294 |
0.0039 |
| 910 |
DIZZINESS |
1936 |
0.0039 |
| 911 |
PRURITUS |
1465 |
0.0038 |
| 912 |
RESTLESSNESS |
138 |
0.0038 |
| 913 |
VERTIGO |
229 |
0.0038 |
| 914 |
LIMB DISCOMFORT |
116 |
0.0037 |
| 915 |
ABNORMAL BEHAVIOUR |
147 |
0.0037 |
| 916 |
WEIGHT INCREASED |
828 |
0.0037 |
| 917 |
BALANCE DISORDER |
319 |
0.0037 |
| 918 |
UNEVALUABLE EVENT |
277 |
0.0037 |
| 919 |
VISION BLURRED |
501 |
0.0036 |
| 920 |
MOBILITY DECREASED |
261 |
0.0036 |
| 921 |
SLEEP DISORDER |
256 |
0.0036 |
| 922 |
NASAL CONGESTION |
212 |
0.0036 |
| 923 |
RASH MACULAR |
126 |
0.0036 |
| 924 |
VISUAL IMPAIRMENT |
443 |
0.0036 |
| 925 |
MEMORY IMPAIRMENT |
491 |
0.0036 |
| 926 |
HOSPITALISATION |
544 |
0.0035 |
| 927 |
DRY MOUTH |
287 |
0.0035 |
| 928 |
INFLUENZA LIKE ILLNESS |
284 |
0.0034 |
| 929 |
URTICARIA |
574 |
0.0034 |
| 930 |
NO ADVERSE EVENT |
618 |
0.0034 |
| 931 |
ANGIOEDEMA |
150 |
0.0034 |
| 932 |
CONTUSION |
325 |
0.0034 |
| 933 |
AMNESIA |
216 |
0.0033 |
| 934 |
BLOOD PRESSURE INCREASED |
503 |
0.0033 |
| 935 |
ABDOMINAL DISCOMFORT |
550 |
0.0033 |
| 936 |
DRY EYE |
163 |
0.0033 |
| 937 |
INSOMNIA |
867 |
0.0033 |
| 938 |
DYSKINESIA |
132 |
0.0032 |
| 939 |
ADVERSE DRUG REACTION |
290 |
0.0032 |
| 940 |
HOT FLUSH |
243 |
0.0032 |
| 941 |
DEPRESSION |
731 |
0.0032 |
| 942 |
THERAPY INTERRUPTED |
229 |
0.0032 |
| 943 |
PERIPHERAL SWELLING |
492 |
0.0032 |
| 944 |
BURNING SENSATION |
223 |
0.0032 |
| 945 |
ANXIETY |
900 |
0.0032 |
| 946 |
ARTHROPATHY |
174 |
0.0031 |
| 947 |
PROSTATE CANCER |
250 |
0.0031 |
| 948 |
OSTEOARTHRITIS |
131 |
0.0031 |
| 949 |
DEPRESSED MOOD |
163 |
0.0031 |
| 950 |
ASTHMA |
346 |
0.0031 |
| 951 |
FLUSHING |
308 |
0.0030 |
| 952 |
NEPHROLITHIASIS |
138 |
0.0030 |
| 953 |
SKIN IRRITATION |
137 |
0.0030 |
| 954 |
UNDERDOSE |
218 |
0.0030 |
| 955 |
MUSCLE SPASMS |
545 |
0.0030 |
| 956 |
MEDICATION ERROR |
163 |
0.0029 |
| 957 |
ABORTION SPONTANEOUS |
116 |
0.0029 |
| 958 |
ARTHRITIS |
225 |
0.0029 |
| 959 |
EMOTIONAL DISTRESS |
340 |
0.0028 |
| 960 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
134 |
0.0028 |
| 961 |
MUSCULOSKELETAL STIFFNESS |
242 |
0.0028 |
| 962 |
VAGINAL HAEMORRHAGE |
119 |
0.0027 |
| 963 |
NASOPHARYNGITIS |
505 |
0.0027 |
| 964 |
FLATULENCE |
153 |
0.0027 |
| 965 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
120 |
0.0027 |
| 966 |
FEELING HOT |
160 |
0.0026 |
| 967 |
DRY SKIN |
337 |
0.0025 |
| 968 |
EYE PAIN |
142 |
0.0025 |
| 969 |
ECZEMA |
130 |
0.0025 |
| 970 |
JOINT SWELLING |
278 |
0.0023 |
| 971 |
SURGERY |
131 |
0.0022 |
| 972 |
ILLNESS |
229 |
0.0022 |
| 973 |
BLOOD GLUCOSE INCREASED |
411 |
0.0022 |
| 974 |
BLADDER CANCER |
125 |
0.0021 |
| 975 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
373 |
0.0021 |
| 976 |
IRRITABILITY |
123 |
0.0020 |
| 977 |
SKIN BURNING SENSATION |
146 |
0.0020 |
| 978 |
INJECTION SITE REACTION |
129 |
0.0019 |
| 979 |
OVERDOSE |
400 |
0.0019 |
| 980 |
INJURY |
127 |
0.0018 |
| 981 |
RHEUMATOID ARTHRITIS |
197 |
0.0017 |
| 982 |
FEELING ABNORMAL |
407 |
0.0017 |
| 983 |
INTENTIONAL PRODUCT MISUSE |
142 |
0.0016 |
| 984 |
MIGRAINE |
150 |
0.0016 |
| 985 |
DRUG DOSE OMISSION |
158 |
0.0010 |
| 986 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
177 |
0.0009 |
| 987 |
PRODUCT DOSE OMISSION ISSUE |
251 |
0.0009 |
| 988 |
INCORRECT DOSE ADMINISTERED |
169 |
0.0007 |
| 989 |
INJECTION SITE PAIN |
158 |
0.0005 |